Is Metformin-Induced Vitamin B12 Deficiency Responsible for Cognitive Decline in Type 2 Diabetes?

Deepti Khattar, Farah Khaliq, Neelam Vaney, S V Madhu, Deepti Khattar, Farah Khaliq, Neelam Vaney, S V Madhu

Abstract

Introduction: Diabetes mellitus has its deleterious effects on various aspects of cognition such as memory function, executive function, and information-processing speed. The present study aims to assess cognition in diabetes patients and also tries to find its association with Vitamin B12 deficiency induced by metformin.

Materials and methods: Thirty diabetics taking metformin and thirty nondiabetic controls were enrolled. Event-related potentials (ERPs) and serum Vitamin B12 levels were evaluated in them.

Results: Vitamin B12 levels were found to be deficient, and latencies of waves P200 and P300 were prolonged in the diabetics as compared to the controls. The dose and duration of metformin had no association with the ERPs.

Conclusions: Although the Vitamin B12 levels were deficient in diabetics on metformin, this is not the reason behind the cognitive impairment found in them.

Keywords: Cognition; Vitamin B12 levels; event-related potentials; metformin.

References

    1. Marar O, Senturk S, Agha A, Thompson C, Smith D. The prevalence of Vitamin B12 deficiency in patients with type 2 diabetes mellitus on metformin. R Coll Surg Irel Stud Med J. 2011;4:16–20.
    1. Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Economou FN. Metformin: An old medication of new fashion: Evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur J Endocrinol. 2010;162:193–212.
    1. Ting RZ, Szeto CC, Chan MH, Ma KK, Chow KM. Risk factors of Vitamin B12 deficiency in patients receiving metformin. Arch Intern Med. 2006;166:1975–9.
    1. Kawamura T, Umemura T, Hotta N. Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? J Diabetes Investig. 2012;3:413–23.
    1. van den Berg E, Kessels RP, Kappelle LJ, de Haan EH, Biessels GJ. Utrecht Diabetic Encephalopathy Study Group. Type 2 diabetes, cognitive function and dementia: Vascular and metabolic determinants. Drugs Today (Barc) 2006;42:741–54.
    1. Khattar D, Sodhi C, Parmod J, Dutta A. Correlating estrogen levels and cognitive functions in regularly menstruating females of reproductive age group and post-menopausal women of North India. J Family Reprod Health. 2015;9:83–8.
    1. Sadock BJ, Sadock VA. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2003.
    1. Wechsler D. WMS-R Manual. New York: Psychological Corporation; 1987.
    1. Reitan R, Davidson L, editors. Clinical Neuropsychology, Current Status and Applications. New York: John Wiley; 1974.
    1. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271–6.
    1. Bird TD, Miller BL. Alzheimer's disease and other dementias. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 16th ed. Vol. II. USA: McGraw Hill; 2005. pp. 2393–406.
    1. Pozzessere G, Valle E, de Crignis S, Cordischi VM, Fattapposta F, Rizzo PA, et al. Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis. Comparison with short-latency evoked potentials and psychometric tests. Diabetes. 1991;40:952–8.
    1. Anjana Y, Khaliq F, Vaney N. Event-related potentials study in attention deficit hyperactivity disorder. Funct Neurol. 2010;25:87–92.
    1. Khaliq F, Alam KK, Vaney N, Singh TB. Sensory, cognitive and motor assessment of children with poor academic performance: An auditory evoked potential study. Indian J Physiol Pharmacol. 2010;54:255–64.
    1. Picton TW, Hillyard SA. Human auditory evoked potentials. II. Effects of attention. Electroencephalogr Clin Neurophysiol. 1974;36:191–9.
    1. Ritter W, Ford JM, Gaillard AW, Harter MR, Kutas M, Näätänen R, et al. Cognition and event-related potentials. I. The relation of negative potentials and cognitive processes. Ann N Y Acad Sci. 1984;425:24–38.
    1. Smith ME, Halgren E, Sokolik M, Baudena P, Musolino A, Liegeois-Chauvel C, et al. The intracranial topography of the P3 event-related potential elicited during auditory oddball. Electroencephalogr Clin Neurophysiol. 1990;76:235–48.
    1. Picton TW. The P300 wave of the human event-related potential. J Clin Neurophysiol. 1992;9:456–79.
    1. Donchin E, Coles MG. Is the P300 component a manifestation of context updating? Behav Brain Sci. 1988;11:357–74.
    1. Andrès E, Noel E, Goichot B. Metformin-associated Vitamin B12 deficiency. Arch Intern Med. 2002;162:2251–2.
    1. Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses Vitamin B12 malabsorption induced by metformin. Diabetes Care. 2000;23:1227–31.
    1. Wile DJ, Toth C. Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care. 2010;33:156–61.
    1. Munshi M, Grande L, Hayes M, Ayres D, Suhl E, Capelson R, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care. 2006;29:1794–9.
    1. Messier C. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol Aging. 2005;26(Suppl 1):26–30.
    1. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol. 2006;5:64–74.
    1. Strachan MW. The brain as a target organ in Type 2 diabetes: Exploring the links with cognitive impairment and dementia. Diabet Med. 2011;28:141–7.
    1. Young SE, Mainous AG, 3rd, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care. 2006;29:2688–93.
    1. Ding J, Strachan MW, Reynolds RM, Frier BM, Deary IJ, Fowkes FG, et al. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study. Diabetes. 2010;59:2883–9.
    1. Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis: A viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res. 2009;32:115–21.
    1. Ryan CM. Diabetes, aging, and cognitive decline. Neurobiol Aging. 2005;26(Suppl 1):21–5.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi